Influenza A(H5N1) in Cattle and Goats

Influenza A(H5N1) was known as an Highly Pathogenic Avian Influenza (HPAI). Most scientists were worried that, with some small mututions, the virus would be able to infect humans too. Cattle and goats, however, were assumed to be at low risk of contracting Influenza A(H5N1).

Now, in March 2024, both cattle and goats are reported to be infected across multiple states of the United States. Potentially worse, there are some signs that cow-to-cow transmission may already have occurred.

Influenza A(H5N1) is highly virulent and was first detected in dairy cows in Texas and Kansas at the end of March 2024. Since then the virus has spread to additional herds. As of early April 2024, cases have been reported among dairy herds in Texas (7), Kansas (2), Michigan (1), New Mexico (1), and Ohio (1).

Cattle impacted by Influenza A(H5N1) exhibit flu-like symptoms, including fever and thick and discolored milk accompanied by a sharp reduction in milk production. Economic impacts to facilities are ongoing as herds that are greatly impacted may lose up to 40% of their milk production for 7 to 10 days until symptoms subside.

Cattle is a known mixing vessel for Influenza. The virus will have mutated to better infect these cows and goats. Which means that Influenza A(H5N1) is one step closer to become virulent enough to infect humans on the large scale.

On April 1, 2024 news appeared that the first human case of Influenza A(H5N1) infection was found in Texas. Also, the next day, a cat was found positive for Influenza A(H5N1).

Sequences from the dairy cows matched with those from wild bird samples collected from Texas about the same time. However, the goat samples from Minnesota are most similar to a pheasant sequence from Colorado.

Worldwide, Influenza A(H5N1) virus infections have been reported in more than 890 people with approximately 50% case fatality rate since 1997. Mild upper respiratory tract symptoms, lower respiratory tract disease, severe pneumonia with respiratory failure, encephalitis, and multi-organ failure have been reported.

Luckily, a vaccine is already in development[1].

[1] Beukenhorst et al: A pan-influenza monoclonal antibody neutralizes H5 strains and prophylactically protects through intranasal administration in Science Reports - 2024